Cargando…

Identification of relevant genetic alterations in cancer using topological data analysis

Large-scale cancer genomic studies enable the systematic identification of mutations that lead to the genesis and progression of tumors, uncovering the underlying molecular mechanisms and potential therapies. While some such mutations are recurrently found in many tumors, many others exist solely wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabadán, Raúl, Mohamedi, Yamina, Rubin, Udi, Chu, Tim, Alghalith, Adam N., Elliott, Oliver, Arnés, Luis, Cal, Santiago, Obaya, Álvaro J., Levine, Arnold J., Cámara, Pablo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393176/
https://www.ncbi.nlm.nih.gov/pubmed/32732999
http://dx.doi.org/10.1038/s41467-020-17659-7
Descripción
Sumario:Large-scale cancer genomic studies enable the systematic identification of mutations that lead to the genesis and progression of tumors, uncovering the underlying molecular mechanisms and potential therapies. While some such mutations are recurrently found in many tumors, many others exist solely within a few samples, precluding detection by conventional recurrence-based statistical approaches. Integrated analysis of somatic mutations and RNA expression data across 12 tumor types reveals that mutations of cancer genes are usually accompanied by substantial changes in expression. We use topological data analysis to leverage this observation and uncover 38 elusive candidate cancer-associated genes, including inactivating mutations of the metalloproteinase ADAMTS12 in lung adenocarcinoma. We show that ADAMTS12(−/−) mice have a five-fold increase in the susceptibility to develop lung tumors, confirming the role of ADAMTS12 as a tumor suppressor gene. Our results demonstrate that data integration through topological techniques can increase our ability to identify previously unreported cancer-related alterations.